Cidara Therapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
San Diego, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Cidara Therapeutics, Inc. has filed 798 SEC EDGAR filings since 17 Jun 2014

SEC filing history

Showing 76-100 of 798 matching filings.

Per page
25
Current page
4
SCHEDULE 13G/A File 005-88806

SCHEDULE 13G/A filing

Filing date
17 Oct 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36912

CIDARA THERAPEUTICS, INC. FORM 8-K

Filing date
06 Oct 2025
Reporting date
30 Sep 2025
Next action
Verify source filing
4

FORM 4

Filing date
15 Sep 2025
Reporting date
11 Sep 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD File 001-36912

UPLOAD filing

Filing date
04 Sep 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
26 Aug 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A File 005-88806

SCHEDULE 13G/A filing

Filing date
14 Aug 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A File 005-88806

SCHEDULE 13G/A filing

Filing date
14 Aug 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A File 005-88806

SCHEDULE 13G/A filing

Filing date
14 Aug 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A File 005-88806

SCHEDULE 13G/A filing

Filing date
14 Aug 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD File 001-36912

UPLOAD filing

Filing date
13 Aug 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A File 005-88806

SCHEDULE 13G/A filing

Filing date
12 Aug 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A File 005-88806

SCHEDULE 13G/A filing

Filing date
12 Aug 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13D/A File 005-88806

SCHEDULE 13D/A filing

Filing date
11 Aug 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-289363

CIDARA THERAPEUTICS, INC. FORM S-8

Filing date
07 Aug 2025
Reporting date
Not listed
Next action
Verify source filing
10-Q File 001-36912

CIDARA THERAPEUTICS, INC. FORM 10-Q

Filing date
07 Aug 2025
Reporting date
30 Jun 2025
Next action
Verify source filing
8-K File 001-36912

CIDARA THERAPEUTICS, INC. FORM 8-K

Filing date
07 Aug 2025
Reporting date
07 Aug 2025
Next action
Verify source filing
SCHEDULE 13G File 005-88806

SCHEDULE 13G filing

Filing date
30 Jul 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G File 005-88806

SCHEDULE 13G filing

Filing date
17 Jul 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G File 005-88806

SCHEDULE 13G filing

Filing date
02 Jul 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13D/A File 005-88806

SCHEDULE 13D/A filing

Filing date
30 Jun 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
30 Jun 2025
Reporting date
26 Jun 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-287104

424B5

Filing date
25 Jun 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .